Dr. Pepper Snapple Group reported a decline in fourth-quarter sales but still managed to beat Wall Street expectations. Excluding items, the soft drinks maker reported earnings of 97 cents a share, beating analyst expectations for earnings of 85 cents a share, according to Thomson Reuters. Dr Pepper acknowledged that its soda division continues to face significant headwinds as U.S. soda consumption has been on the decline. Sales volume fell by 4% -- which was partially offset by higher prices, according to the company.
More from Video
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.